Actively Recruiting
Spotting and Managing Adult Repeated Traumas in the Brain
Led by Université de Montréal · Updated on 2025-07-20
200
Participants Needed
3
Research Sites
156 weeks
Total Duration
On this page
Sponsors
U
Université de Montréal
Lead Sponsor
U
University of Victoria
Collaborating Sponsor
AI-Summary
What this Trial Is About
Emerging evidence suggests that concussions (a type of mild traumatic brain injury; mTBIs) may cause chronic neurological disturbances with effects lasting beyond 20 years, changing brain structure and nearly doubling the risks of developing dementia into old age. Yet diagnoses remain notoriously difficult, gender differences are poorly understood, and negligible therapies exist to manage and treat these long-term effects. This project proposes using a combination of NeuroTracker (a promising software-based cognitive assessment and intervention for mild TBIs), with the latest MRI techniques and blood-based biomarkers of brain function, to provide unprecedented assessment sensitivity of long-term concussion effects, comparing older male and female adults, with and without a history of concussion. Additionally, NeuroTracker will be used as a therapeutic intervention to improve outcomes in adults with histories of concussion, with the combined assessments measuring efficacy pre-post training. This project aims to comprehensively understand the impacts of mild brain traumas into later life, via both physical and functional biomarkers of brain health. It will also validate the value of NeuroTracker as an accessible training intervention for recovering cognitive functions impacted by earlier-life concussions.
CONDITIONS
Official Title
Spotting and Managing Adult Repeated Traumas in the Brain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older
- History of concussion with the most recent concussion occurring at least one year prior to the study
- Ability to provide detailed information about each concussion experienced, including cause, symptoms, diagnosis, and recovery
- Willingness to provide information on age, sex, gender, education, occupation, and medical history
You will not qualify if you...
- Diagnosed neurological disorders such as Mild Cognitive Impairment, Alzheimer's disease, or Parkinson's disease
- History of severe psychiatric disorders including schizophrenia
- Use of medications or conditions that could affect cognition, such as psychotropic or anticholinergic drugs
- Diagnosed visual impairments that could interfere with NeuroTracker training, including severe color blindness, monocular vision, or blindness
- Contraindications for MRI such as presence of metal implants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Christie Lab
Victoria, British Columbia, Canada, V8N 4V3
Actively Recruiting
2
Jodie Gawryluk
Victoria, British Columbia, Canada, V8N 4V3
Actively Recruiting
3
Faubert Lab
Montreal, Quebec, Canada, H3T 1P1
Actively Recruiting
Research Team
E
Eduardo Lugo Project Manager, PhD
CONTACT
B
Brian Christie Co-Investigator, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here